CRISPR Patent Outcome: Zhang Feng's team provides CRISPR gene editing technology free of charge to academia around the world.

The European Patent Office recently announced plans to grant a patent for "gene shear" CRISPR in Europe to the University of California, Berkeley, which includes 23 compositions such as single-molecule DNA targeting RNA and their associated research methods and kits.
the announcement, MIT and Harvard Broad Institute sent their statements about the incident to a reporter from Science and Technology Daily on the 28th.
, CRISPR research is a large area involving the contributions of many talented scientists from around the world.
as of March 2017, the U.S. Patent and Trademark Office has issued 55 CRISPR-related patents to approximately 100 inventors in 18 organizations, half of them academic institutions.
The European Patent Office has also issued 21 related patents to 30 inventors from about 10 applicants.
the European patent examination process is different from that of the United States, where a patent right may be adjusted if there is an objection within nine months of the issuance of the patent.
once an objection has been filed, the European Patent Office will need to review it.
examination process usually takes one year, after which the European Patent Office may make a decision to uphold, revoke or permit the modification of the patent.
is widely expected that the parties concerned will file objections and that adjustments by the European Patent Office in this case are necessary.
in the next few years, more inventors will emerge from the CRISPR field, and more patents will be granted in recognition of everyone who has contributed to advancing CRISPR technology.
statement that the global scientific community will continue to use CRISPR technology to advance human understanding of biology and disease treatment and help lay the foundation for a new generation of therapies.
This is in keeping with the Broad Institute's fundamental principles for advancing understanding and treating diseases, and the Broad Institute and its partners will continue to work to maximize the public interest by continuing to make this transformative technology available free of charge to academia around the world and by conducting commercial human therapy research through inclusive and innovative models.
source: ScienceDaily.